Your institution may have access to this item. Find your institution then sign in to continue.
Title
Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.
Authors
Pi-Sunyer FX; Aronne LJ; Heshmati HM; Devin J; Rosenstock J; RIO-North American Study Group; Pi-Sunyer, F Xavier; Aronne, Louis J; Heshmati, Hassan M; Devin, Jeanne; Rosenstock, Julio; RIO-North America Study Group
Publication
JAMA: Journal of the American Medical Association, 2006, Vol 295, Issue 7, p761